According to a new report by Reports and Data, the Global Left ventricular assist device (LVAD) Market  size was valued at USD 1,329.2 Million in 2020 and is forecast to reach USD 3,014.1 Million, at a CAGR of 11.3% through 2028. The market growth is driven by changing lifestyle habits, rise in geriatric population, and technological advancements in the healthcare sector.

The global geriatric population base in expanding a faster pace. This section of the population is highly prone to cardiovascular diseases, which has resulted in an increased demand for cardiovascular care. This, in turn is positively impacting LVAD market growth.

Nearly 18 million deaths occur annually across the globe due to cardiovascular diseases. Such high death rate associated with cardiovascular diseases have promoted increased investment in the healthcare sector to minimize the number of deaths related to the condition. The shortage of a suitable heart donor is fuelling the adoption of ventricular assist devices (VADs) among CVD patients. Favorable outcomes associated with LVAD, such as improved survival rate, longevity, durability, and functionality of these devices are anticipated to boost Left Ventricular Assist Device Market size through 2028

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1477

The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.

Key companies operating in the market include:

global left ventricular assist device market include Sunshine Heart, Sun Medical Technology Research, CorWave, Apaxis Inc., Evaheart, Abiomed, Jarvik Heart, HeartWare International, Reliantheart, Transonic, Thoratec, Terumo, and HeartWare International among others.

 The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.

The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Left Ventricular Assist Device (LVAD)  market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.

On basis of product types and application offered by the Left Ventricular Assist Device (LVAD)  industry, the market is segmented into:

Type Outlook (Revenue, USD Billion; 2020-2028)

• Transcutaneous LVAD
• Implantable LVAD

Age group Type Outlook (Revenue, USD Billion; 2020-2028)

• 20-39 years
• 40-59 years
• 60-79 years

Pump type Outlook (Revenue, USD Billion; 2020-2028)

• Pulsatile volume-displacement pumps
• First-Generation Devices
• Axial flow pumps
• Second-Generation Devices
• Continuous flow centrifugal pumps
• Third-Generation Devices

Application Type Outlook (Revenue, USD Billion; 2020-2028)

• Bridge-to-Recovery (BTR) Therapy
• Bridge-to-Transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-Candidacy (BTC) Therapy

End-user Outlook (Revenue, USD Billion; 2020-2028)

• Cardiology Centers
• Hospitals

The regional analysis covers:

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Italy
  • France
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East Africa
  • Saudi Arabia
  • A.E.
  • South Africa
  • Rest of MEA

Benefits of Left Ventricular Assist Device (LVAD)  Market Report:

• Panoramic overview of the opportunities and risks in the Left Ventricular Assist Device (LVAD) sector
• Study of recent innovations and developments in the industry
• Comprehensive study of the growth pattern of the Left Ventricular Assist Device (LVAD) industry
• In-depth assessment of the competitive landscape of the key players of the Left Ventricular Assist Device (LVAD) industry
• Analysis of the Left Ventricular Assist Device (LVAD) market drivers, constraints, and opportunities
• Assessment of technological developments and latest trends of the industry

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1477

Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.